BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1371576)

  • 21. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
    Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galanin is a physiological regulator of spontaneous pulsatile secretion of growth hormone in the male rat.
    Maiter DM; Hooi SC; Koenig JI; Martin JB
    Endocrinology; 1990 Feb; 126(2):1216-22. PubMed ID: 1688791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of free fatty acids and arginine on growth hormone secretion in man.
    Maccario M; Procopio M; Loche S; Cappa M; Martina V; Camanni F; Ghigo E
    Metabolism; 1994 Feb; 43(2):223-6. PubMed ID: 8121306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galanin abolishes the inhibitory effect of cholinergic blockade on growth hormone-releasing hormone-induced secretion of growth hormone in man.
    Chatterjee VK; Ball JA; Proby C; Burrin JM; Bloom SR
    J Endocrinol; 1988 Feb; 116(2):R1-2. PubMed ID: 2450944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of metoclopramide on the growth hormone response to galanin in normal man.
    Giustina A; Bussi AR; Doga M; Licini M; Schettino M; Wehrenberg WB
    Horm Metab Res; 1993 Sep; 25(9):489-92. PubMed ID: 7693566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin-28 and somatostatin-14 suppression of arginine-, insulin-, and TRH-stimulated GH and PRL secretion in man.
    Millar RP; Klaff LJ; Barron JL; Levitt NS; Ling N
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):277-85. PubMed ID: 6134596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man.
    Ahrén B
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):591-7. PubMed ID: 1704674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
    Maccario M; Procopio M; Grottoli S; Oleandri SE; Boffano GM; Taliano M; Camanni F; Ghigo E
    Metabolism; 1996 Mar; 45(3):342-6. PubMed ID: 8606641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
    Loche S; Vista N; Ghigo E; Vannelli S; Arvat E; Benso L; Corda R; Cella SG; Müller EE; Pintor C
    Pediatr Res; 1990 Apr; 27(4 Pt 1):405-7. PubMed ID: 1692988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of galanin on growth hormone secretion in children of normal and short stature.
    Loche S; Cella SG; Puggioni R; Stabilini L; Pintor C; Müller EE
    Pediatr Res; 1989 Oct; 26(4):316-9. PubMed ID: 2477790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin.
    Davis TM; Burrin JM; Bloom SR
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1248-52. PubMed ID: 2445773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism.
    Giustina A; Bussi AR; Legati F; Bossoni S; Licini M; Schettino M; Zuccato F; Wehrenberg WB
    Acta Endocrinol (Copenh); 1992 Dec; 127(6):504-8. PubMed ID: 1283476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
    Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion.
    Koppeschaar HP; ten Horn CD; Thijssen JH; Page MD; Dieguez C; Scanlon MF
    Clin Endocrinol (Oxf); 1992 May; 36(5):487-90. PubMed ID: 1617799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humans.
    Todd JF; Edwards CM; Ghatei MA; Bloom SR
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1060-6. PubMed ID: 10827009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
    Ghigo E; Miola C; Aimaretti G; Valente F; Procopio M; Arvat E; Yin-Zhang W; Camanni F
    Metabolism; 1992 Sep; 41(9):1000-3. PubMed ID: 1355580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.